Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Anthelios UVMune 400
- Development stage
- Unknown
- Lead developer
- La Roche-Posay
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Anthelios UVMune 400 is a high-protection topical sunscreen line developed by La Roche-Posay, a brand under L'Oréal. The formulation features the proprietary UV filter Mexoryl 400 (Methoxypropylamino Cyclohexenylidene Ethycyanoacetate), which is specifically engineered to absorb ultra-long UVA radiation in the 380–400 nm range. These wavelengths penetrate deeply into the dermis and are significant contributors to photoaging, DNA damage, and hyperpigmentary disorders. The product is utilized in clinical settings to manage and prevent conditions such as melasma, post-inflammatory hyperpigmentation (PIHP), and acne-related skin darkening, often in combination with other topical agents like niacinamide or thiamidol.
- Brand names
- Anthelios UVMune 400UV MuneUV Mune 400
- Other names
- La Roche-Posay Anthelios UVMune 400
Beyond the preview
Go deeper on Anthelios UVMune 400.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anthelios UVMune 400.